ストックスクリーナーアプリを入手
3.78
1.82%
-0.07
アフターアワーズ：
3.78
前日終値:
$3.85
開ける：
$3.89
24時間の取引高:
3,199
Relative Volume:
0.24
時価総額：
$69.14M
収益：
-
当期純損益:
$-12.63M
株価収益率:
-5.4451
EPS:
-0.6942
ネットキャッシュフロー:
$-12.18M
1週間 パフォーマンス:
-3.08%
1か月 パフォーマンス:
+15.60%
6か月 パフォーマンス:
+0.53%
1年 パフォーマンス:
+4.13%
1日の値動き範囲:
$3.7141
$3.89
1週間の範囲:
$3.51
$4.00
52週間の値動き範囲:
$2.74
$7.28
Genenta Science Spa Adr Stock (GNTA) Company Profile
GNTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
3.78 | 71.33M | 0 | -12.63M | -12.18M | -0.6942 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-06-29 | 再開されました | ROTH MKM | Buy |
| 2022-07-25 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-13 | 開始されました | Maxim Group | Buy |
Genenta Science Spa Adr (GNTA) 最新ニュース
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail
Genenta Science stock maintains Buy rating as Temferon shows promise in GBM - Investing.com
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewswire Inc.
Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa
Genenta secures €20M in mandatory convertible bond deal - Investing.com India
Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa
Genenta secures $21.9 million for cancer drug trial - Investing.com India
Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks
Genenta Science Secures €20 Million Financing to Boost Cancer Therapy Development - TipRanks
Oncology Breakthroughs: How Cancer Research Is Advancing in 202527.02.25News - Ariva
Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance
Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks
Genenta Science Announces Shareholder Meeting - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
10 Best Italian Stocks To Buy Now - Yahoo Finance
Genenta Science Spa Adr (GNTA) 財務データ
収益
当期純利益
現金流量
EPS
0.64%
0.37%
大文字化:
|
ボリューム (24 時間):